1-4 of 4
Mustafa Pehlivan, MD
Close
Sort by
Journal Articles

Real-World Data in Relapsed Refractory Myeloma Patients Treated with Carfilzomib, a Multicenter Turkish Experience

Omur Gokmen Sevindik, MD, Mustafa Pehlivan, MD, Tulin F Tuglular, MD, Serife M Solmaz, MD, Mehmet Hilmi Dogu, Fevzi Yalniz, MD, Ali Ugur Ural, MD, Zafer Serenli Yeğen, MD, Mutlu Arat, MD, Vildan Ozkocaman, MD, Elif G Umit, MD, Handan Haydaroğlu Şahin, MD, Mehmet Sönmez, MD, Mehmet Turgut, MD, Muhit Ozcan, MD, Onder Arslan, MD, Yildiz Aydin, MD, Tayfun Elibol, MD, Aybuke Harmandali Olgun, MD, Banu Bayar, MD, Anil Tombak, MD, Ismet Aydogdu, MD, Güner Hayri Özsan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5405.
https://doi.org/10.1182/blood.V130.Suppl_1.5405.5405
Published: 2017
Journal Articles

Real-World Data in Relapsed Refractory Myeloma Patients Treated with Pomalidomide, a Multicenter Turkish Experience

Guner Hayri Ozsan, MD, Omur Gokmen Sevindik, MD, Sevil Sadri, MD, Sibel Kabukcu Hacioglu, MD, Sureyya Yigit Kaya, MD, Ayfer Geduk, MD, Ali Ugur Ural, MD, Tulin F Tuglular, MD, Vildan Ozkocaman, MD, Ahmet Muzaffer Demir, MD, Yildiz Aydin, MD, Gulsum Akgun Cagliyan, MD, Ismet Aydogdu, MD, Mustafa Pehlivan, MD, Ibrahim Muaz Yaradilmis, MD, Volkan Karakus, MD, Mehmet Yilmaz, MD, Meral Beksac, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5430.
https://doi.org/10.1182/blood.V130.Suppl_1.5430.5430
Published: 2017
Journal Articles

Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update

Guray Saydam, MD Prof, Ibrahim Celalettin Haznedaroglu, MD, Leylagul Kaynar, MD, Akif S. Yavuz, MD Prof, Ridvan Ali, Prof MD, Birol Guvenc, MD Prof, Olga M. Akay, MD, Zafer Baslar, Professor Doctor, Ugur Ozbek, MD PhD, Mehmet Sonmez, MD, Demet Aydin, MD, Mustafa Pehlivan, MD Assoc Prof, Bulent Undar, MD Prof, Simten Dagdas, MD Assoc Prof, Orhan M. Ayyildiz, MD Prof, Diyar Z. Akkaynak, MD, Ilkiz M. Dag, MD, Osman Ilhan, MD
Journal: Blood
Blood (2014) 124 (21): 5532.
https://doi.org/10.1182/blood.V124.21.5532.5532
Published: 2014
Journal Articles

Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia

Guray Saydam, MD, Prof, Ibrahim C. Haznedaroglu, MD, Prof, Leylagul Kaynar, MD, Prof, Akif S. Yavuz, MD, Prof, Ridvan Ali, MD, Prof, Birol Guvenc, MD, Prof, Olga M. Akay, MD, Zafer Baslar, Professor Doctor, Ugur Ozbek, MD, Prof, Mehmet Sonmez, M.D., Demet Aydin, MD, Mustafa Pehlivan, MD, Assoc Prof, Bulent Undar, MD, Prof, Simten Dagdas, MD, Assoc Prof, Orhan M. Ayyildiz, MD, Prof, Diyar Z. Akkaynak, MD, Ilkiz M. Dag, MD, Osman Ilhan, MD, Prof
Journal: Blood
Blood (2013) 122 (21): 2742.
https://doi.org/10.1182/blood.V122.21.2742.2742
Published: 2013